NCT01520753View on ClinicalTrials.gov

Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

June 30, 1999

Study Completion Date

June 30, 1999

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

biphasic insulin aspart 70

Administered subcutaneously (s.c., under the skin) at breakfast, lunch and dinner

DRUG

biphasic insulin aspart 70

Administered subcutaneously (s.c., under the skin) at breakfast and lunch

DRUG

biphasic insulin aspart 50

Administered subcutaneously (s.c., under the skin) at dinner

Trial Locations (1)

8000

Novo Nordisk Investigational Site, Århus C

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY